Skip to main content
Top
Published in: Clinical Rheumatology 2/2013

01-02-2013 | Review Article

Advances in research on animal models of rheumatoid arthritis

Authors: Yiping Hu, Wenxiang Cheng, Wenhong Cai, Ye Yue, Jinchao Li, Peng Zhang

Published in: Clinical Rheumatology | Issue 2/2013

Login to get access

Abstract

At present, rheumatoid arthritis (RA) is considered a type of autoimmune disease. Its pathology is not certain, and effective drugs with less toxicity have not been established. The establishment and application of animal models are effective methods for RA research, especially using animal models similar to humans. Arthritis is more heterogeneous, and this is an important starting point when discussing animal models for arthritis. Animal models are instrumental in understanding the etiology and pathogenetic mechanisms of RA. Appropriate animal models should be selected according to experiments because they have different traits. Various methods have been applied to induce arthritis in animal experimental models, which have provided important insights into the etiopathogenetic mechanisms of human RA. This review was written to give a broad introduction of the current stage of RA model and hope to offer beneficial help for RA-related research.
Literature
1.
go back to reference Di Paola R, Cuzzocrea S (2008) Predictivity and sensitivity of animal models of arthritis. Autoimmun Rev 8(1):73–75PubMedCrossRef Di Paola R, Cuzzocrea S (2008) Predictivity and sensitivity of animal models of arthritis. Autoimmun Rev 8(1):73–75PubMedCrossRef
2.
3.
go back to reference Huh JE, Hong JM, Baek YH et al (2011) Anti-inflammatory and anti-nociceptive effect of Betula platyphylla var. japonica in human interleukin-1beta-stimulated fibroblast-like synoviocytes and in experimental animal models. J Ethnopharmacol 135(1):126–134PubMedCrossRef Huh JE, Hong JM, Baek YH et al (2011) Anti-inflammatory and anti-nociceptive effect of Betula platyphylla var. japonica in human interleukin-1beta-stimulated fibroblast-like synoviocytes and in experimental animal models. J Ethnopharmacol 135(1):126–134PubMedCrossRef
4.
go back to reference Chang J, Kavanaugh A (2005) Novel therapies for rheumatoid arthritis. Pathophysiology 12(3):217–225PubMedCrossRef Chang J, Kavanaugh A (2005) Novel therapies for rheumatoid arthritis. Pathophysiology 12(3):217–225PubMedCrossRef
5.
go back to reference Vital EM, Emery P (2008) The development of targeted therapies in rheumatoid arthritis. J Autoimmun 31(3):219–227PubMedCrossRef Vital EM, Emery P (2008) The development of targeted therapies in rheumatoid arthritis. J Autoimmun 31(3):219–227PubMedCrossRef
6.
go back to reference Villa-Forte A, Mandell BF (2011) Cardiovascular disorders and rheumatic disease. Rev Esp Cardiol 64(9):809–817PubMedCrossRef Villa-Forte A, Mandell BF (2011) Cardiovascular disorders and rheumatic disease. Rev Esp Cardiol 64(9):809–817PubMedCrossRef
7.
go back to reference Zhang P, Han D, Tang T et al (2008) Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm Res 57(7):322–328PubMedCrossRef Zhang P, Han D, Tang T et al (2008) Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm Res 57(7):322–328PubMedCrossRef
8.
go back to reference Seeuws S, Jacques P, Van Praet J, Drennan M et al (2010) A multiparameter approach to monitor disease activity in collagen-induced arthritis. Arthritis Res Ther 12(4):R160PubMedCrossRef Seeuws S, Jacques P, Van Praet J, Drennan M et al (2010) A multiparameter approach to monitor disease activity in collagen-induced arthritis. Arthritis Res Ther 12(4):R160PubMedCrossRef
9.
go back to reference Carlsen S, Hansson AS, Olsson H et al (1998) Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol 114(3):477–484PubMedCrossRef Carlsen S, Hansson AS, Olsson H et al (1998) Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol 114(3):477–484PubMedCrossRef
10.
go back to reference Meyer DM, Jesson MI, Li X, Elrick MM et al (2010) Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis. J Inflamm (Lond) 7:41CrossRef Meyer DM, Jesson MI, Li X, Elrick MM et al (2010) Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis. J Inflamm (Lond) 7:41CrossRef
11.
go back to reference Vingsbo C, Jonsson R, Holmdahl R (1995) Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 99(8):359–363PubMed Vingsbo C, Jonsson R, Holmdahl R (1995) Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 99(8):359–363PubMed
12.
go back to reference Zhu W, Meng L, Jiang C, Hou W, Xu J, Wang B et al (2011) Induction of toll-like receptor 2 positive antigen-presenting cells in spleen of pristane-induced arthritis in rats. Mol Biol Rep 39(3):3667–3673PubMed Zhu W, Meng L, Jiang C, Hou W, Xu J, Wang B et al (2011) Induction of toll-like receptor 2 positive antigen-presenting cells in spleen of pristane-induced arthritis in rats. Mol Biol Rep 39(3):3667–3673PubMed
13.
go back to reference Meng L, Zhu W, Jiang C, He X, Hou W et al (2010) Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats. Arthritis Res Ther 12(3):R103PubMedCrossRef Meng L, Zhu W, Jiang C, He X, Hou W et al (2010) Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats. Arthritis Res Ther 12(3):R103PubMedCrossRef
14.
go back to reference Jansson AM, Lorentzen JC, Bucht A (2000) CD8+ cells suppress oil-induced arthritis. Clin Exp Immunol 120(19):532–536PubMedCrossRef Jansson AM, Lorentzen JC, Bucht A (2000) CD8+ cells suppress oil-induced arthritis. Clin Exp Immunol 120(19):532–536PubMedCrossRef
15.
go back to reference Perruche S, Saas P, Chen W (2009) Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy? Arthritis Res Ther 11(4):R104PubMedCrossRef Perruche S, Saas P, Chen W (2009) Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy? Arthritis Res Ther 11(4):R104PubMedCrossRef
16.
go back to reference Nagate T, Tamura T, Sato F, Kuroda J et al (2007) Tranilast suppresses the disease development of the adjuvant- and streptococcal cell wall-induced arthritis in rats. J Pharmacol Sci 105(1):48–56PubMedCrossRef Nagate T, Tamura T, Sato F, Kuroda J et al (2007) Tranilast suppresses the disease development of the adjuvant- and streptococcal cell wall-induced arthritis in rats. J Pharmacol Sci 105(1):48–56PubMedCrossRef
17.
go back to reference Holmdahl R, Bockermann R, Backlund J, Yamada H (2000) The molecular pathogenesis of collagen-induced arthritis in mice–a model for rheumatoid arthritis. Ageing Res Rev 1(1):135–147CrossRef Holmdahl R, Bockermann R, Backlund J, Yamada H (2000) The molecular pathogenesis of collagen-induced arthritis in mice–a model for rheumatoid arthritis. Ageing Res Rev 1(1):135–147CrossRef
18.
go back to reference Glant TT, Radacs M, Nagyeri G, Olasz K et al (2011) Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis. Arthritis Rheum 63(5):1312–1321PubMedCrossRef Glant TT, Radacs M, Nagyeri G, Olasz K et al (2011) Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis. Arthritis Rheum 63(5):1312–1321PubMedCrossRef
19.
go back to reference Sakiniene E, Collins LV (2002) Combined antibiotic and free radical trap treatment is effective at combating Staphylococcus aureus-induced septic arthritis. Arthritis Res 4(1):196–200PubMedCrossRef Sakiniene E, Collins LV (2002) Combined antibiotic and free radical trap treatment is effective at combating Staphylococcus aureus-induced septic arthritis. Arthritis Res 4(1):196–200PubMedCrossRef
20.
go back to reference Henningsson L, Jirholt P, Lindholm C, Eneljung T et al (2010) Interleukin-17A during local and systemic Staphylococcus aureus-induced arthritis in mice. Infect Immun 78(9):3783–3790PubMedCrossRef Henningsson L, Jirholt P, Lindholm C, Eneljung T et al (2010) Interleukin-17A during local and systemic Staphylococcus aureus-induced arthritis in mice. Infect Immun 78(9):3783–3790PubMedCrossRef
21.
go back to reference Ma Y, Seiler KP, Eichwald EJ, Weis JH et al (1998) Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun 66(1):161–168PubMed Ma Y, Seiler KP, Eichwald EJ, Weis JH et al (1998) Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun 66(1):161–168PubMed
22.
go back to reference Kay J, Calabrese L (2004) The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatol (Oxford) 43(3):iii2–iii9CrossRef Kay J, Calabrese L (2004) The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatol (Oxford) 43(3):iii2–iii9CrossRef
23.
go back to reference Pizarro TT, Arseneau KO, Cominelli F (2000) Lessons from genetically engineered animal models XI. Novel mouse models to study pathogenic mechanisms of Crohn’s disease. Am J Physiol Gastrointest Liver Physiol 278(1):G665–G669PubMed Pizarro TT, Arseneau KO, Cominelli F (2000) Lessons from genetically engineered animal models XI. Novel mouse models to study pathogenic mechanisms of Crohn’s disease. Am J Physiol Gastrointest Liver Physiol 278(1):G665–G669PubMed
24.
go back to reference Okura T, Marutsuka K, Hamada H, Sekimoto T et al (2008) Therapeutic efficacy of intra-articular adrenomedullin injection in antigen-induced arthritis in rabbits. Arthritis Res Ther 10(6):R133PubMedCrossRef Okura T, Marutsuka K, Hamada H, Sekimoto T et al (2008) Therapeutic efficacy of intra-articular adrenomedullin injection in antigen-induced arthritis in rabbits. Arthritis Res Ther 10(6):R133PubMedCrossRef
25.
go back to reference Martinez-Lostao L, Garcia-Alvarez F, Basanez G, Alegre-Aguaron E et al (2010) Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis. Arthritis Rheum 62(8):2272–2282PubMedCrossRef Martinez-Lostao L, Garcia-Alvarez F, Basanez G, Alegre-Aguaron E et al (2010) Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis. Arthritis Rheum 62(8):2272–2282PubMedCrossRef
26.
go back to reference Benito MJ, Sanchez-Pernaute O, Lopez-Armada MJ, Hernandez P et al (2000) Cyclosporin A prevents the histologic damage of antigen arthritis without inducing fibrosis. Arthritis Rheum 43(2):311–319PubMedCrossRef Benito MJ, Sanchez-Pernaute O, Lopez-Armada MJ, Hernandez P et al (2000) Cyclosporin A prevents the histologic damage of antigen arthritis without inducing fibrosis. Arthritis Rheum 43(2):311–319PubMedCrossRef
27.
go back to reference Kranenburg HC, Westerveld LA, Verlaan JJ, Oner FC et al (2010) The dog as an animal model for DISH? Eur Spine J 19(8):1325–1329PubMedCrossRef Kranenburg HC, Westerveld LA, Verlaan JJ, Oner FC et al (2010) The dog as an animal model for DISH? Eur Spine J 19(8):1325–1329PubMedCrossRef
28.
go back to reference Cook JL, Kuroki K, Visco D, Pelletier JP, Schulz L, Lafeber FP (2010) The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in the dog. Osteoarthr Cartil 18(3):S66–S79PubMedCrossRef Cook JL, Kuroki K, Visco D, Pelletier JP, Schulz L, Lafeber FP (2010) The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in the dog. Osteoarthr Cartil 18(3):S66–S79PubMedCrossRef
29.
go back to reference Mihara M, Kotoh M, Nishimoto N, Oda Y, Kumagai E et al (2001) Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys. Clin Immunol 98(3):319–326PubMedCrossRef Mihara M, Kotoh M, Nishimoto N, Oda Y, Kumagai E et al (2001) Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys. Clin Immunol 98(3):319–326PubMedCrossRef
30.
go back to reference Kato A, Matsuo S, Takai H, Uchiyama Y, Mihara M, Suzuki M (2008) Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model. Exp Mol Pathol 84(3):262–270PubMedCrossRef Kato A, Matsuo S, Takai H, Uchiyama Y, Mihara M, Suzuki M (2008) Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model. Exp Mol Pathol 84(3):262–270PubMedCrossRef
Metadata
Title
Advances in research on animal models of rheumatoid arthritis
Authors
Yiping Hu
Wenxiang Cheng
Wenhong Cai
Ye Yue
Jinchao Li
Peng Zhang
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-012-2041-1

Other articles of this Issue 2/2013

Clinical Rheumatology 2/2013 Go to the issue